CliffBio
small molecule

INDIUM IN 111 CHLORIDE

INDIUM IN-111 CHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyCurium Pharma →See this company's full patent-cliff portfolio

Drug detail

Brand nameINDIUM IN 111 CHLORIDE
Active ingredientINDIUM IN-111 CHLORIDE
Strength5mCi/0.5ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalSeptember 1994
Marketing statusDISCN

More from Curium Pharma

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.